SCHEMBL20182449

SCHEMBL20182449

CN1c2ccncc2C(=O)NC1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.36
ADORA2A P29274 2/20 0.36
ADORA1 P30542 1/20 0.36
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 2/20 0.35
NPSR1 Q6W5P4 3/20 0.34
ROCK2 O75116 2/20 0.34
HSD17B10 Q99714 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
CYP3A4 P08684 3/20 0.32
CDC25B P30305 1/20 0.32
ROCK1 Q13464 1/20 0.32
DAO P14920 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
CDC7 O00311 1/20 0.31
THRB P10828 1/20 0.31
TSHR P16473 1/20 0.31
THPO P40225 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182601 0.88 ADORA3 (0.38) ADORA3ADORA2AADORA1KDM4EALDH1A1
SCHEMBL20182603 0.77 ALDH1A1 (0.55) KDM4EALDH1A1ROCK2HSD17B10TSHR
SCHEMBL20011113 0.72 CDC7 (0.39) ADORA3ADORA2ANPSR1MAOAMAOB
SCHEMBL20182650 0.72 MKNK2 (0.37) ALDH1A1HSD17B10CYP3A4CDC25BCYP2C9
SCHEMBL20205797 0.69 ADORA3 (0.38) ADORA3ADORA2AADORA1KDM4EALDH1A1
SCHEMBL20808936 0.69 CASP2 (0.35) KDM4EALDH1A1MEN1KMT2A
SCHEMBL5227409 0.64 NPSR1 (0.56) KDM4EALDH1A1NPSR1HSD17B10MAOA
SCHEMBL2474607 0.62 TTR (0.55) ADORA3ADORA2AKDM4EALDH1A1NPSR1
SCHEMBL20182463 0.62 TNKS2 (0.32)
SCHEMBL24499037 0.61 HDAC1 (0.42) ADORA3ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10278973-B2 Hydroxyl purine compounds and use thereof Guangdong Raynovent Biotech Co., Ltd. (CN) 2019-05-07 US disclosed
US-20180140607-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF Guangdong Raynovent Biotech Co., Ltd. (CN) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180140607-A1 HYDROXYL PURINE COMPOUNDS AND USE THEREOF PNP, PDE7A, PDE2A ADORA3 99/4885ADORA2A 30/4885ADORA1 87/4885
US-10278973-B2 Hydroxyl purine compounds and use thereof PNP, PDE7A, PDE2A ADORA3 99/4885ADORA2A 30/4885ADORA1 87/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.